Price
CHART BY
Frequently asked questions
What is Synlab's market capitalization?
The market capitalization of Synlab is $3.19B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Synlab's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Synlab is 31.34. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Synlab?
Synlab's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.462. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Synlab's stock?
Currently, 1 analysts cover Synlab's stock, with a consensus target price of $11.40. Analyst ratings provide insights into the stock's expected performance.
What is Synlab's revenue over the trailing twelve months?
Over the trailing twelve months, Synlab reported a revenue of $2.98B.
What is the EBITDA for Synlab?
Synlab's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $488.37M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Synlab?
Synlab has a free cash flow of $259.52M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Synlab have, and what sector and industry does it belong to?
Synlab employs approximately 27,047 people. It operates in the Health Care sector, specifically within the Medical/ Nursing Services industry.
What is the free float of Synlab's shares?
The free float of Synlab is 31.31M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $3.19B
- EPS (TTM)
- $0.462
- Free Float
- 31.31M
- P/E ratio (TTM)
- 31.34
- Revenue (TTM)
- $2.98B
- EBITDA (TTM)
- $488.37M
- Free Cashflow (TTM)
- $259.52M
Pricing
- 1D span
- $14.29$14.63
- 52W span
- $11.54$14.73
Analyst Ratings
The price target is $11.40 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The firm offers medical diagnostic information for patients, practicing doctors, clinics, and the pharmaceutical industry. It operates through the following geographical segments: France, Germany, South Region, and North and East Regions. The company was founded by Bartholomaeus Wimmer in 1998 and is headquartered in Munich, Germany.
- Employees
- 27,047
- Industries
- Medical/ Nursing Services
- Sector
- Health Care
Identifier
- ISIN
- DE000A2TSL71
- Primary Ticker
- SYAB
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet